Skip to content

Stichting Kankerregister

Active
Public-utility foundationfounded 200521 yrs activeGalileelaan 5, 1210 Sint-Joost-ten-Node, BelgiumKBO/BCE: BE 0874.845.671
Summary

For the legal form of Stichting Kankerregister, Checked does not compute a bankruptcy probability. The 2025 annual accounts show equity of €4.57M and a net result of €187k. Equity is growing by ~3.4% per year across the filed fiscal years. Its solvency ranks better than 65% of 508 sector peers (fiscal year 2025). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
81 / 100
Excellent▼ -9 vs 2024
Axes · tick = 2024
Profitability49▼-22
Solvency100=
Growth78=
Track record100
Credit verdict
Credit up to €360k at 30 days acceptable
Liquidity ample (current ratio 5.57 against 7.95 in 2024; short-term debt: 17.8% and cash: 65.6% of total assets), and 23.3% of the assets are financed with debt.
Credit check for your own amount and term

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-03-2026, 123 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
123 d early
2024
129 d early
2023
126 d early
2022
111 d early
2021
125 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€187k▲ 100%
2024 · €93k
2018: €9k 2019: €332k▲ +3618% vs 2018highest in 8 years 2020: €225k▼ -32.1% vs 2019 2021: €205k▼ -9.2% vs 2020 2022: €269k▲ +31.4% vs 2021 2023: €-209k▼ -178% vs 2022lowest in 8 years 2024: €93k▲ +145% vs 2023 2025: €187k▲ +100% vs 2024
2018 → 2025
Working capital
€4.84M▲ 9.3%
2024 · €4.42M
2018: €3.86Mlowest in 8 years 2019: €4.16M▲ +7.8% vs 2018 2020: €3.92M▼ -5.7% vs 2019 2021: €4.21M▲ +7.3% vs 2020 2022: €4.55M▲ +8.1% vs 2021 2023: €4.28M▼ -5.9% vs 2022 2024: €4.42M▲ +3.5% vs 2023 2025: €4.84M▲ +9.3% vs 2024highest in 8 years
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€4.23M-€4.50M▲ 6.3%€4.29M▼ 4.7%€4.38M▲ 2.2%€4.57M▲ 4.3% 2021: €4.23Mlowest in 5 years 2022: €4.50M▲ +6.3% vs 2021 2023: €4.29M▼ -4.7% vs 2022 2024: €4.38M▲ +2.2% vs 2023 2025: €4.57M▲ +4.3% vs 2024highest in 5 years
Operating result€205k-€269k▲ 31.4%€-209k€93k€283k▲ 203% 2021: €205k 2022: €269k▲ +31.4% vs 2021 2023: €-209k▼ -178% vs 2022lowest in 5 years 2024: €93k▲ +145% vs 2023 2025: €283k▲ +203% vs 2024highest in 5 years
Net result€205k-€269k▲ 31.4%€-209k€93k€187k▲ 100% 2021: €205k 2022: €269k▲ +31.4% vs 2021highest in 5 years 2023: €-209k▼ -178% vs 2022lowest in 5 years 2024: €93k▲ +145% vs 2023 2025: €187k▲ +100% vs 2024
Result per fiscal year
Operating resultNet result
€-400k€-200k€0€200kOperating result 2021: €205k€205kNet result 2021: €205k€205kOperating result 2022: €269k€269kNet result 2022: €269k€269kOperating result 2023: €-209k€-209kNet result 2023: €-209k€-209kOperating result 2024: €93k€93kNet result 2024: €93k€93kOperating result 2025: €283k€283kNet result 2025: €187k€187k20212022202320242025€-400k€-200k€0€200kOperating result 2023: €-209k€-209kNet result 2023: €-209k€-209kOperating result 2024: €93k€93kNet result 2024: €93k€93kOperating result 2025: €283k€283kNet result 2025: €187k€187k202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 203% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.95M
Fixed assets €61k ▼ 25.8%
Current assets €5.89M ▲ 16.5%
Equity and liabilities €5.95M
Equity €4.57M ▲ 4.3%
Provisions €203k
Debt €1.18M ▲ 55.4%
Debt's share of the balance-sheet total rises from 14.8% to 19.9%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€301k▲
2024 · €99k
Cash flow
€205k▲
2024 · €99k
Current ratio
5.57▼
2024 · 7.95
Debt to equity
0.26▲
2024 · 0.17
ROE
4.1%▲
2024 · 2.1%
ROA
3.1%▲
2024 · 1.8%
Interest coverage
3.11▼
2024 · 1985480.20
Debt ≤ 1 year
€1.06M▲
2024 · €636k
Staff costs
€4.98M▲
2024 · €4.95M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet Code20242025
Assets
Total assets20/58€5.14M€5.95M▲
Fixed assets21/28€82k€61k▼
Tangible fixed assets22/27€11k€7k▼
Furniture and vehicles24€4k€3k▼
Other tangible fixed assets26€7k€4k▼
Financial fixed assets28€71k€53k▼
Current assets29/58€5.06M€5.89M▲
Amounts receivable within one year40/41€1.13M€1.95M▲
Trade receivables40€12k€213k▲
Other amounts receivable41€1.12M€1.74M▲
Cash at bank and in hand54/58€3.88M€3.91M▲
Deferred charges and accrued income490/1€50k€31k▼
Equity and liabilities
Total equity and liabilities10/49€5.14M€5.95M▲
Equity10/15€4.38M€4.57M▲
Contributions10/11€2.42M€2.42M=
Capital10€2.42M€2.42M=
Reserves13€1.31M€1.31M=
Profit (loss) carried forward14€652k€838k▲
Provisions and deferred taxes16-€203k
Provisions for liabilities and charges160/5-€203k
Other liabilities and charges164/5-€203k
Amounts payable17/49€762k€1.18M▲
Amounts payable within one year42/48€636k€1.06M▲
Trade debts44€81k€488k▲
Suppliers440/4€81k€488k▲
Taxes, remuneration and social security45€552k€567k▲
Taxes450/3€4k€8k▲
Remuneration and social security454/9€548k€559k▲
Accrued charges and deferred income492/3€126k€125k=
Income statement Code20242025
Goods, raw materials, services and sundry goods60/61€1.96M€2.18M▲
Remuneration, social security and pensions62€4.95M€4.98M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€18k▲
Other operating charges640/8-€42k
Gross operating margin9900€5.05M€5.53M▲
Operating profit (loss)9901€93k€283k▲
Financial income75/76B€10€653▲
Recurring financial income75€10€653▲
Financial charges65/66B€0€97k▲
Recurring financial charges65€0€97k▲
Profit (loss) for the period before taxes9903€93k€187k▲
Profit (loss) for the period9904€93k€187k▲
Profit (loss) for the period to be appropriated9905€93k€187k▲
Appropriation of the result
Profit (loss) to be appropriated9906€652k€838k▲
Profit (loss) brought forward from the previous period14P€558k€652k▲
Social balance
Average headcount (FTE)908754.553.3▼

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Goods, raw materials, services and sundry goods60/61-€1.81M€2.18M€1.96M€2.18M▲ 11.4%
Remuneration, social security and pensions62-€3.68M€4.70M€4.95M€4.98M▲ 0.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29k€22k€30k€6k€18k▲ 203%
Other operating charges640/8-€18k€25k-€42k-
Gross operating margin9900€3.52M€3.99M€4.55M€5.05M€5.53M▲ 9.5%
Operating profit (loss)9901€205k€269k€-209k€93k€283k▲ 203%
Financial income75/76B-€10€385€10€653▲ 6,214%
Recurring financial income75€65€10€385€10€653▲ 6,214%
Financial charges65/66B-€32€207€0€97k▲ 193,569,700%
Recurring financial charges65€119€32€207€0€97k▲ 193,569,700%
Profit (loss) for the period before taxes9903€205k€269k€-209k€93k€187k▲ 100%
Profit (loss) for the period9904€205k€269k€-209k€93k€187k▲ 100%
Profit (loss) for the period to be appropriated9905€205k€269k€-209k€93k€187k▲ 100%
Line20212022202320242025Change
Assets
Total assets20/58€5.51M€5.31M€5.04M€5.14M€5.95M▲ 15.8%
Fixed assets21/28€99k€92k€87k€82k€61k▼ 25.8%
Tangible fixed assets22/27€29k€21k€16k€11k€7k▼ 33.8%
Furniture and vehicles24-€5k€5k€4k€3k▼ 28.6%
Other tangible fixed assets26-€16k€11k€7k€4k▼ 37.3%
Financial fixed assets28€70k€71k€71k€71k€53k▼ 24.6%
Current assets29/58€5.41M€5.22M€4.95M€5.06M€5.89M▲ 16.5%
Amounts receivable within one year40/41€868k€1.09M€1.07M€1.13M€1.95M▲ 73.0%
Trade receivables40-€7k€42k€12k€213k▲ 1,658%
Other amounts receivable41-€1.09M€1.02M€1.12M€1.74M▲ 55.8%
Cash at bank and in hand54/58€4.50M€4.06M€3.83M€3.88M€3.91M▲ 0.7%
Deferred charges and accrued income490/1-€64k€60k€50k€31k▼ 38.3%
Equity and liabilities
Total equity and liabilities10/49€5.51M€5.31M€5.04M€5.14M€5.95M▲ 15.8%
Equity10/15€4.23M€4.50M€4.29M€4.38M€4.57M▲ 4.3%
Contributions10/11-€2.42M€2.42M€2.42M€2.42M=
Capital10-€2.42M€2.42M€2.42M€2.42M=
Reserves13-€1.52M€1.31M€1.31M€1.31M=
Profit (loss) carried forward14€616k€558k€558k€652k€838k▲ 28.6%
Provisions and deferred taxes16----€203k-
Provisions for liabilities and charges160/5----€203k-
Other liabilities and charges164/5----€203k-
Amounts payable17/49€1.28M€816k€751k€762k€1.18M▲ 55.4%
Amounts payable within one year42/48€1.20M€676k€676k€636k€1.06M▲ 66.4%
Trade debts44€836k€217k€101k€81k€488k▲ 506%
Suppliers440/4-€217k€101k€81k€488k▲ 506%
Taxes, remuneration and social security45-€454k€571k€552k€567k▲ 2.7%
Taxes450/3-€651€1k€4k€8k▲ 112%
Remuneration and social security454/9-€454k€570k€548k€559k▲ 2.0%
Accrued charges and deferred income492/3-€141k€75k€126k€125k=
Line20212022202320242025Change
Profit (loss) for the period9904€205k€269k€-209k€93k€187k▲ 100%
+ Depreciation and write-downs630€29k€22k€30k€6k€18k▲ 203%
Operating cash flow (approximation)€234k€290k€-179k€99k€205k▲ 106%
Investment in fixed assets (approximation)-€-15k€-25k€-1k€3k▲ 364%
Change in cash-€-431k€-239k€55k€27k▼ 50.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-03
NBB filing Annual accounts filed
fiscal year 2025 · full schema
30-03
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
19-02
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 04-02-2026
  • Registered-office move, Galileelaan 5 bus 6, 1210 Sint-Joost-ten-Node (België)
22-01
State Gazette act Appointment: Sylvia Van Snick (director)
Resignation: Hedwig Dubois (director)3 facts ▸
  • Board meeting, 30-09-2025
  • Director appointment, Sylvia Van Snick (director)
  • Director resignation, Hedwig Dubois (director)
05-01
State Gazette act Resignations: Jean Bronckaers (director) and Bert Winnen (director)
4 facts ▸
  • Board meeting, 19-03-2020
  • Board meeting, 24-03-2022
  • Director resignation, Jean Bronckaers (director)
  • Director resignation, Bert Winnen (director)
2025
17-07
State Gazette act Appointment: Heidi Reynders (director)
Resignation: Astrid Janssens (director)3 facts ▸
  • Board meeting, 25-06-2025
  • Director appointment, Heidi Reynders (director)
  • Director resignation, Astrid Janssens (director)
24-03
NBB filing Annual accounts filed
fiscal year 2024 · full schema
24-03
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Back to profitnet €93k
Net result €93k after one loss-making year.
08-11
State Gazette act Appointment: Annick Antierens (director)
Resignation: Danica Zamurovic (director)3 facts ▸
  • Board meeting, 23-09-2024
  • Director appointment, Annick Antierens (director)
  • Director resignation, Danica Zamurovic (director)
27-03
NBB filing Annual accounts filed
fiscal year 2023 · full schema
27-03
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
Show earlier events
05-03
State Gazette act Appointments: Astrid Janssens, Guillaume Westenbohm and Marie Clopterop
Resignation: Heidi Reynders (director) · Power of attorney6 facts ▸
  • Board meeting, 23-10-2023
  • Director appointment, Astrid Janssens (director)
  • Director resignation, Heidi Reynders (director)
  • Director appointment, Guillaume Westenbohm (director)
  • Power of attorney, Stichting Kankerregister
  • Director appointment, Marie Clopterop (bijzonder lasthebber)
2023
31-12
Financial Weakest financial yearnet €-209k
Net result drops to €-209k, the lowest in the series; recovery starts the following year.
30-10
State Gazette act Statutes amendment
3 facts ▸
  • Board meeting, 23-10-2023
  • Statutes amendment
  • Statutes amendment
20-04
State Gazette act Appointments: Dr. Carina Bonnewyn (director) and BE AUDIT BV (statutory auditor)
Resignation: Dr. Steven Luyten (director)4 facts ▸
  • Board meeting, 23-03-2023
  • Director appointment, Dr. Carina Bonnewyn (director)
  • Director resignation, Dr. Steven Luyten (director)
  • Auditor appointment, BE AUDIT BV
11-04
NBB filing Annual accounts filed
fiscal year 2022 · full schema
11-04
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
19-04
State Gazette act Appointments: Anouk Waeytens, Karin De Ridder and 4 others
Reappointments: Dominique de Valériola, Michiel Callens and 9 others · Resignations: Herman Van Oyen (director) and Dominique Bron (director)20 facts ▸
  • Board meeting, 24-03-2022
  • Director appointment, Anouk Waeytens (director)
  • Director appointment, Karin De Ridder (director)
  • Director reappointment, Dominique de Valériola (director)
  • Director appointment, Stephan Devriese (director)
  • Director reappointment, Michiel Callens (director)
  • Director reappointment, Alex Peltier (director)
  • Director reappointment, Steven Luyten (director)
  • Director reappointment, Heidi Reynders (director)
  • Director reappointment, Philiep Berkein (director)
  • Director reappointment, Ann Ceuppens (director)
  • Director reappointment, Danica Zamurovic (director)
  • +8 further facts in this act
28-03
NBB filing Annual accounts filed
fiscal year 2021 · full schema
28-03
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
02-02
State Gazette act Appointment: Dr Heidi Reyners (director)
Resignation: Dr Anna Katharina Mortelmans (director)2 facts ▸
  • Director appointment, Dr Heidi Reyners (director)
  • Director resignation, Dr Anna Katharina Mortelmans (director)
2021
23-11
State Gazette act Appointment: Dr. Heidi Reynders (director)
Resignation: Dr. Anna Katharina Mortelmans (director)2 facts ▸
  • Director appointment, Dr. Heidi Reynders (director)
  • Director resignation, Dr. Anna Katharina Mortelmans (director)
28-06
State Gazette act Resignation: Dr. Katrien Mortelmans (director)
Note2 facts ▸
  • Director resignation, Dr. Katrien Mortelmans (director)
  • Note, no replacement appointed
17-05
State Gazette act Reappointment: Stichting Kankerregister (director)
3 facts ▸
  • Board meeting, 18-03-2021
  • Director reappointment, Stichting Kankerregister (director)
  • Director reappointment, Stichting Kankerregister (director)
2020
01-09
State Gazette act Appointments: Steven Luyten (vertegenwoordiger in de raad van bestuur) and Bert Winnen (vertegenwoordiger in de raad van bestuur)
2 facts ▸
  • Director appointment, Steven Luyten (vertegenwoordiger in de raad van bestuur)
  • Director appointment, Bert Winnen (vertegenwoordiger in de raad van bestuur)
26-06
State Gazette act Appointment: Quali-audit (statutory auditor)
Mandate compensation3 facts ▸
  • Board meeting, 19-03-2020
  • Auditor appointment, Quali-audit (statutory auditor)
  • Mandate compensation, Quali-audit
26-06
State Gazette act Appointment: BV Quali-Audit - réviseurs d'entreprises (statutory auditor)
Mandate compensation4 facts ▸
  • Board meeting, 19-03-2020
  • Auditor appointment, BV Quali-Audit - réviseurs d'entreprises (statutory auditor)
  • Mandate compensation, BV Quali-Audit - réviseurs d'entreprises
  • Mandate compensation, BV Quali-Audit - réviseurs d'entreprises
2019
31-12
Financial Highest result since 2018net €332k ▲3,618%
Operating result €332k, net result €332k, both a record.
29-11
State Gazette act Resignations: Ivana Widera (director) and Leo Jousten (director)
2 facts ▸
  • Director resignation, Ivana Widera (director)
  • Director resignation, Leo Jousten (director)
23-10
State Gazette act Resignations: Laurence Nick (director) and Jean-Pierre Schenkelaars (director)
Appointment: Alex Peltier (director)3 facts ▸
  • Director resignation, Laurence Nick (director)
  • Director resignation, Jean-Pierre Schenkelaars (director)
  • Director appointment, Alex Peltier (director)
2018
16-11
State Gazette act Resignation: Martine Duyck (vertegenwoordiger in de raad van bestuur)
Appointments: Katrien Mortelmans (vertegenwoordiger in de raad van bestuur) and Elise Mendes da Costa (vertegenwoordiger in de raad van bestuur)3 facts ▸
  • Director resignation, Martine Duyck (vertegenwoordiger in de raad van bestuur)
  • Director appointment, Katrien Mortelmans (vertegenwoordiger in de raad van bestuur)
  • Director appointment, Elise Mendes da Costa (vertegenwoordiger in de raad van bestuur)
16-11
State Gazette act Resignation: Henri De Ridder (director)
1 fact ▸
  • Director resignation, Henri De Ridder (director)
09-02
State Gazette act Resignations: Murielle Deguerry (director) and Valerie Keutgen (director)
2 facts ▸
  • Director resignation, Murielle Deguerry (director)
  • Director resignation, Valerie Keutgen (director)
2017
21-08
State Gazette act Resignation: Raf Vanstechelman (vertegenwoordiger voor de hulpkas voor ziekte en invaliditeitsverzekering)
Appointment: Danica Zamurovic (vertegenwoordiger in de raad van bestuur)3 facts ▸
  • Board meeting, 14-06-2017
  • Director resignation, Raf Vanstechelman (vertegenwoordiger voor de hulpkas voor ziekte en invaliditeitsverzekering)
  • Director appointment, Danica Zamurovic (vertegenwoordiger in de raad van bestuur)
21-04
State Gazette act Appointment: Burg. BVBA "DGST & PARTNERS Bedrijfsrevisoren" (statutory auditor)
Permanent representative: Ghislain Dochen · Mandate compensation4 facts ▸
  • Board meeting
  • Auditor appointment, Burg. BVBA "DGST & PARTNERS Bedrijfsrevisoren" (statutory auditor)
  • Permanent representative, Ghislain Dochen
  • Mandate compensation, Burg. BVBA "DGST & PARTNERS Bedrijfsrevisoren"
13-02
State Gazette act Resignation: Brigitte Van Rompaey (vertegenwoordiger voor de kas van de geneeskundige verzorging van de nmbs holding hrrail)
Appointments: Hedwig Dubois (vertegenwoordiger in de raad van bestuur) and Laurence Nick (vertegenwoordiger in de raad van bestuur)4 facts ▸
  • Board meeting, 20-12-2016
  • Director resignation, Brigitte Van Rompaey (vertegenwoordiger voor de kas van de geneeskundige verzorging van de nmbs holding hrrail)
  • Director appointment, Hedwig Dubois (vertegenwoordiger in de raad van bestuur)
  • Director appointment, Laurence Nick (vertegenwoordiger in de raad van bestuur)
2016
11-03
State Gazette act Reappointments: Dr. Herman Van Oyen, Dr. Dominique de Valériola and 11 others
Appointments: Dr. Dominique Bron, Mevr. Valérie Keutgen and 3 others · Resignation: Dr. Sabine Debled (vertegenwoordiger voor de franse gemeenschap)21 facts ▸
  • General meeting, 22-09-2015
  • Director reappointment, Dr. Herman Van Oyen (vertegenwoordiger ministerie van sociale zaken en volksgezondheid)
  • Director reappointment, Dr. Dominique de Valériola (vertegenwoordiger ministerie van sociale zaken en volksgezondheid)
  • Director reappointment, Dr. Ri De Ridder (vertegenwoordiger ministerie van sociale zaken en volksgezondheid)
  • Director reappointment, Dr. Karin Haustermans (vertegenwoordiger ministerie van de vlaamse gemeenschap)
  • Director reappointment, Dr. Murielle Deguerry (vertegenwoordiger ministerie van het brussels hoofdstedelijk gewest)
  • Director reappointment, Dr. Michiel Callens (vertegenwoordiger verzekeringsinstellingen)
  • Director reappointment, Dr. Jean-Pierre Bronckaers (vertegenwoordiger verzekeringsinstellingen)
  • Director reappointment, Dr. Martine Duyck (vertegenwoordiger verzekeringsinstellingen)
  • Director reappointment, Dr. Jean-Pierre Schenkelaers (vertegenwoordiger verzekeringsinstellingen)
  • Director reappointment, Dr. Philippe Berkein (vertegenwoordiger verzekeringsinstellingen)
  • Director reappointment, Dr. Ann Ceuppens (vertegenwoordiger verzekeringsinstellingen)
  • +9 further facts in this act
2015
03-03
State Gazette act Resignation: Christian Jaminon (director)
2 facts ▸
  • Board meeting, 23-09-2014
  • Director resignation, Christian Jaminon (director)
2014
25-11
State Gazette act Appointment: Régis Van Caillie (statutory auditor)
1 fact ▸
  • Auditor appointment, Régis Van Caillie (statutory auditor)
06-01
State Gazette act Resignation: Yves Van houte (representative)
Appointments: Joannes Petrus Schenkelaars (representative) and Sabine Debled (representative)4 facts ▸
  • Board meeting, 18-12-2013
  • Director resignation, Yves Van houte (representative)
  • Director appointment, Joannes Petrus Schenkelaars (representative)
  • Director appointment, Sabine Debled (representative)
2013
19-12
State Gazette act Resignation: Didier Vander Steichel (bestuurder, vertegenwoordiger voor de franstalige gemeenschap)
2 facts ▸
  • Board meeting, 05-09-2013
  • Director resignation, Didier Vander Steichel (bestuurder, vertegenwoordiger voor de franstalige gemeenschap)
19-12
State Gazette act Appointment: dr. de Valeriola Dominique (vice-chair)
2 facts ▸
  • Board meeting, 05-09-2013
  • Director appointment, dr. de Valeriola Dominique (vice-chair)
19-09
State Gazette act Appointment: Henri De Ridder (director)
1 fact ▸
  • Director appointment, Henri De Ridder (director)
10-05
State Gazette act Resignation: Jean-Paul Dercq (director)
2 facts ▸
  • Board meeting, 28-03-2013
  • Director resignation, Jean-Paul Dercq (director)
18-03
State Gazette act Resignation: Myriam De Spiegelaere (vertegenwoordiger voor de gemeenschappelijke gemeenschapscommissie van brussel hoofdstad)
Appointment: Murielle Deguerry (representative)2 facts ▸
  • Director resignation, Myriam De Spiegelaere (vertegenwoordiger voor de gemeenschappelijke gemeenschapscommissie van brussel hoofdstad)
  • Director appointment, Murielle Deguerry (representative)
2012
20-07
State Gazette act Resignation: Lucia Schneiders (vertegenwoordiger voor de duitstalige gemeenschap)
Appointment: Christan Jaminon (vertegenwoordiger voor de duitstalige gemeenschap)2 facts ▸
  • Director resignation, Lucia Schneiders (vertegenwoordiger voor de duitstalige gemeenschap)
  • Director appointment, Christan Jaminon (vertegenwoordiger voor de duitstalige gemeenschap)
20-07
State Gazette act Appointment: Régis Van Caillie (statutory auditor)
1 fact ▸
  • Auditor appointment, Régis Van Caillie (statutory auditor)
2011
25-03
State Gazette act Appointment: Jean-Guy DIDIER (wettelijke vertegenwoordiger)
Resignation: Ghislain DOCHEN (wettelijke vertegenwoordiger)2 facts ▸
  • Director appointment, Jean-Guy DIDIER (wettelijke vertegenwoordiger)
  • Director resignation, Ghislain DOCHEN (wettelijke vertegenwoordiger)
2010
02-02
State Gazette act Appointments: Dominique de Valeriola, Jean-Paul Dercq and 14 others
Legal-form conversion · Name change · Statutes amendment19 facts ▸
  • Legal-form conversion, Private Stichting -> Stichting van openbaar nut
  • Name change, Stichting Kankerregister
  • Statutes amendment
  • Director appointment, Dominique de Valeriola (director)
  • Director appointment, Jean-Paul Dercq (director)
  • Director appointment, Françoise Meunier (director)
  • Director appointment, Herman Van Oyen (director)
  • Director appointment, Michael Callens (director)
  • Director appointment, Yves van Houte (director)
  • Director appointment, Martine Duyck (director)
  • Director appointment, Patrick Galloo (director)
  • Director appointment, Jean-Pierre Bronckaers (director)
  • +7 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.
70 of 72 acts read
About the unread acts

Of the 72 Belgian State Gazette acts we know for this company, 70 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
24 directors, last change in 2025
Sylvia Van Snick
Director · since 30-09-2025
Current
Heidi Reynders
Director · since 25-06-2025
Current
Annick Antierens
Director · since 23-09-2024
Current
Guillaume Westenbohm
Director · since 23-10-2023
Current
Marie Clopterop
Bijzonder lasthebber · since 23-10-2023
Current
Dr. Carina Bonnewyn
Director · since 23-03-2023
Current
18 other directors
Anouk Waeytens
Director · since 01-01-2022
Current
Dr. Philippe Berkein
Director · since 01-01-2022
Current
Karin De Ridder
Director · since 01-01-2022
Current
Philiep Berkein
Director · since 01-01-2022
Current
Stephan Devriese
Director · since 01-01-2022
Current
Dr Heidi Reyners
Director · since 23-09-2021
Current
Alex Peltier
Director · since 26-09-2019
Current
Elise Mendes da Costa
Director · since 20-09-2018
Current
Dr. Michiel Callens
Director · since 31-03-2015
Current
Ann Ceuppens
Director · since 30-03-2009
Current
Dominique de Valeriola
Director · since 30-03-2009
Current
Karin Haustermans
Director · since 30-03-2009
Current
Elisabeth Van Eycken
Director (executive) · since 16-01-2008
Current
Jean-Guy DIDIER
Permanent representative · since 01-01-2011
Not recently confirmed
Françoise Meunier
Director · since 30-03-2009
Not recently confirmed
Jean-Pierre Bronckaers
Director · since 30-03-2009
Not recently confirmed
Michael Callens
Director · since 30-03-2009
Not recently confirmed
Patrick Galloo
Director · since 30-03-2009
Not recently confirmed
30-09-2025 Sylvia Van Snick: Appointed as Director
30-09-2025 Sylvia Van Snick: Appointed as Director
30-09-2025 Hedwig Dubois: Resigned as Director
30-09-2025 Hedwig Dubois: Resigned as Director
25-06-2025 Heidi Reynders: Appointed as Director
Full history in the Timeline (206 changes) →
Not every act has been read: a resignation may be missing here
2 of this company's 72 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Sint-Joost-ten-Node · 1 establishment unit since 2005
seat establishment The establishment unit on the map
Ground area
5,994 m²
Building footprint
4,608 m²
Volume, LiDAR
153,694 m³
Parcel 21014A0497/00C000, Brussels · tallest building 58.8 m, ±14 floors. Linked by address, not a title deed.
26 companies at this address See who is registered here
1 establishment unit
Fondation Registre du Cancer, fondation d'utilité publique
Galileelaan 5, 1210 Sint-Joost-ten-NodeActivities of membership organisations
since 20052.149.244.836
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21014A0497/00C000 Brussels 5,994 m² 1 · 4,608 m² 58.8 m · 14 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
BE AUDITCurrent
Auditor
12-04-2023 → present
Show 4 earlier auditors
Burg. BVBA "DGST & PARTNERS Bedrijfsrevisoren"
Statutory auditor · represented by Ghislain Dochen
succeeded by Quali-audit in 2020
31-12-2017 → 31-12-2020
Quali-audit
Statutory auditor
succeeded by BE AUDIT in 2023
31-12-2020 → 12-04-2023
Régis Van Caille
Statutory auditor
succeeded by Burg. BVBA "DGST & PARTNERS Bedrijfsrevisoren" in 2017
20-10-2011 → 31-12-2017
Régis Van Caillie
Statutory auditor
succeeded by Burg. BVBA "DGST & PARTNERS Bedrijfsrevisoren" in 2017
20-10-2011 → 31-12-2017

Articles of association

Purpose
De verzameling, de kwaliteitscontrole, de verwerking, de codering en het opslaan van gegevens; de koppeling met externe gegevensbanken in het kader van preventie, behandeling en…
Full purpose

De verzameling, de kwaliteitscontrole, de verwerking, de codering en het opslaan van gegevens; de koppeling met externe gegevensbanken in het kader van preventie, behandeling en zorg van kanker; de analyse, de mededeling en rapportering, de toegankelijkheid en de bescherming van gegevens. (Incl. specific objectives from KB 78/1967 art 45 quinquies)

Structure & network

Connections & network

19 connected companies
Linked via shared directors
Show 15 more companies with a shared director

Public money · subsidies and aid

Flemish government

2022 to 2025 · 11 entries · 890,308 EUR awarded · 735,503 EUR paid
Year Entries awardedpaid
2025 4 292,598 EUR387,634 EUR
2024 2 50,901 EUR168,936 EUR
2023 3 129,156 EUR139,332 EUR
2022 2 417,653 EUR39,601 EUR
Schemes
AZG - Subsidies partnerorganisaties en organisaties met terreinwerking preventieve gezondheidszorg
4 entries · 378,052 EUR · 348,108 EUR paid · Agentschap Zorg en Gezondheid
DWVG - ZORG - projectsubsidies preventieve gezondheidszorg
1 entry · 244,307 EUR · 195,446 EUR paid · Departement Zorg
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
4 entries · 186,669 EUR · 186,669 EUR paid · Departement Werk en Sociale Economie
Steun voor onderzoeksprojecten
1 entry · 76,000 EUR · Fonds voor wetenschappelijk Onderzoek - Vlaanderen
Individueel Maatwerk
1 entry · 5,280 EUR · 5,280 EUR paid · Departement Werk, Economie, Wetenschap, Innovatie en Sociale Economie

Federal government

2023 to 2025 · 3 entries · 288,363 EUR in total
Year Department Transactions Amount
2025 POD Wetenschapsbeleid 1 115,853 EUR
2024 POD Wetenschapsbeleid 1 94,367 EUR
2023 POD Wetenschapsbeleid 1 78,143 EUR
Budget allocations
Uitgaven verbonden aan de contracten, overeenkomsten en mandaten met betrekking tot de O&O-programma's en -acties op internationaal vlak
3 entries · 288,363 EUR

European research

3 projects · 477,859 EUR EU contribution
Programmes
Horizon Europe
1 entry · 321,250 EUR
Horizon 2020
2 entries · 156,609 EUR
Projects
Multimodal data Integration and AI-based REsearch on environmental exposures in children and Young Adult cancers
Horizon Europe · participant · 01-06-2026 to 31-05-2031 · 321,250 EUR · MIREYA
implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC
Horizon 2020 · participant · 01-10-2015 to 31-03-2019 · 108,313 EUR · ADOPT BBMRI-ERIC
NGS diagnostics in 21st century oncology: the best, for all, at all times
Horizon 2020 · participant · 01-01-2020 to 30-04-2026 · 48,296 EUR · oncNGS

Similar companies · same sector, comparable size

Of 443 companies in sector 94992 we hold annual accounts for 138. 57 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic-utility foundation
Founded04-07-2005
Fiscal year end31-12
Legal name FR Fondation Registre du Cancer
Activities, NACEBEL 2025
94992Activities of membership organisations

Scores and ratios are computed by Checked and are not a credit decision.